Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine (Q40088624)

17 September 2017

Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine (English)

1 reference

17 September 2017

Stephen A Roberts

4

0 references

Tae Hyun Kim

object named as

Tae Hyun Kim

9

0 references

author name string

Hye-Jin Shin

1

1 reference

17 September 2017

Joo-Young Kim

2

1 reference

17 September 2017

Chong-Woo Yoo

3

1 reference

17 September 2017

Sun Lee

5

1 reference

17 September 2017

Soo-Jin Choi

6

1 reference

17 September 2017

Hee-Young Lee

7

1 reference

17 September 2017

Doo-Hyun Lee

8

1 reference

17 September 2017

Kwan Ho Cho

10

1 reference

17 September 2017

28 August 2007

1 reference

Journal of Cancer Research and Clinical Oncology

17 September 2017

1 reference

17 September 2017

134

1 reference

17 September 2017

3

1 reference

17 September 2017

397-404

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-007-0298-6

17 September 2017

0 references

cites work

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0298-6

Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0298-6

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects

21 January 2018

1 reference

12 December 2020

Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.

1 reference

12 December 2020

Tumor microenvironmental physiology and its implications for radiation oncology

1 reference

12 December 2020

Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation.

1 reference

12 December 2020

E7070: a novel synthetic sulfonamide targeting the cell cycle progression for the treatment of cancer

1 reference

12 December 2020

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

1 reference

12 December 2020

DNA damaging effects and voltammetric studies on the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide, SR4233, as a function of pH.

1 reference

12 December 2020

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell

1 reference

12 December 2020

Drugging cell cycle kinases in cancer therapy

1 reference

12 December 2020

DRFIT: a program for fitting radiation survival models

1 reference

12 December 2020

Transcriptional response to hypoxia in human tumors

1 reference

12 December 2020

Angiostatin induces intracellular acidosis and anoikis in endothelial cells at a tumor-like low pH

1 reference

12 December 2020

Radiation-induced apoptosis in different pH environments in vitro

1 reference

12 December 2020

Electrochemical studies and DNA damaging effects of the benzotriazine-N-oxides

1 reference

12 December 2020

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

12 December 2020

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

1 reference

12 December 2020

Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice

1 reference

12 December 2020

Electrochemical properties as a function of pH for the benzotriazine di-N-oxides.

1 reference

12 December 2020

Metabolism of tirapazamine by multiple reductases in the nucleus

1 reference

12 December 2020

Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice

1 reference

12 December 2020

Large-scale analysis of genes that alter sensitivity to the anticancer drug tirapazamine in Saccharomyces cerevisiae

1 reference

12 December 2020

Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.

1 reference

12 December 2020

Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis.

1 reference

12 December 2020

Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells

1 reference

12 December 2020

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

1 reference

12 December 2020

Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer

1 reference

12 December 2020

Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.

1 reference

12 December 2020

10.1007/S00432-007-0298-6

Identifiers

DOI

1 reference

17 September 2017

1 reference